A Phase II Trial Comparing Gemcitabine and Pazopanib Versus Gemcitabine and Docetaxel for Patients With Advanced Soft Tissue Sarcoma

NCT01593748 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

90

Enrollment

OTHER

Sponsor class

Conditions

Sarcoma

Interventions

DRUG: Gemcitabine and Pazopanib
DRUG: Gemcitabine and Docetaxel

Sponsor

Medical University of South Carolina

Collaborators

[object Object]